Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Bristol Myers Squibb - Developments in Genitourinary Cancer Management: Joint Decision Making in MIUC and Advanced RCC

Role of Long-term Efficacy, Safety Outcomes and Different Routes of Administration in the Advance Disease Setting: the RCC Experience

Date

15 Sep 2024

Session

Bristol Myers Squibb - Developments in Genitourinary Cancer Management: Joint Decision Making in MIUC and Advanced RCC

Topics

Immunotherapy

Tumour Site

Renal Cell Cancer

Presenters

Laurence Albiges

Authors

L. Albiges

Author affiliations

  • Medical Oncology Department, Institut Gustave Roussy, 94805 - Villejuif, Cedex/FR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and Introduction

Presenter: Michael Jewett

Session: Bristol Myers Squibb - Developments in Genitourinary Cancer Management: Joint Decision Making in MIUC and Advanced RCC

Resources:

Webcast

Closing Remarks

Presenter: Laurence Albiges

Session: Bristol Myers Squibb - Developments in Genitourinary Cancer Management: Joint Decision Making in MIUC and Advanced RCC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.